Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7

Product Details
Customization: Available
Varieties: General Disease Prevention Medicine
Component: Chemical Synthetic Drugs
Still deciding? Get samples of US$ 60/kg
Request Sample
Manufacturer/Factory & Trading Company

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
360
Year of Establishment
2004-06-18
  • Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7
  • Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7
Find Similar Products

Basic Info.

Model NO.
1kg/bag; 25kg/drum
Type
The First Class
Pharmacodynamic Influential Factors
Combined Medication
Storage Method
Light Proof
Transport Package
Drum
Specification
25kg/drum
Origin
China
HS Code
2941904000
Production Capacity
50000 Kg/Month

Product Description

 
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7
 
Product name
 Lincomycin HCL/ Hydrochloride 
Appearance
White or practically white crystalline powder
CAS No
859-18-7

Introduction
 
Lincomycin hydrochloride appears as a white crystalline powder at room temperature with slight odor or special smell and bitter taste. It is soluble in water.

Use
 
It is mainly used for the treatment of infections caused by Gram-positive bacteria in particular the various penicillin-resistant Gram-positive bacteria , the poultry chronic respiratory disease caused by Mycoplasma, swine enzootic pneumonia, anaerobic infections such as chicken necrotizing enterocolitis.
It can also be used for the treatment of treponema dysentery, toxoplasmosis and actinomycosis of dogs and cats.

Application
 
1. Oral formulations is suitable for treating respiratory infections, abdominal infection, female reproductive tract infections, pelvic infections, skin and soft tissue infections caused by sensitive Staphylococcus aureus and Streptococcus pneumoniae. 
2. In addition to the treatment of the above infections, injected formulations are suitable for treatment of severe infections caused by streptococcus, pneumococcus and staphylococcus such as the surgical adjuvant therapy of septicemia, bone and joint infections, chronic bone and joint infections and Staphylococcus-induced acute hematogenous osteomyelitis. 
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7
Company Profile
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7


Our Team
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7

Office & Factory 
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7

Our Certificates
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7
 
 
Advanced production equipment
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7

Quality Control 
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7

Stock and Shipping
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7

Our Customers
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7

Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7
Apis Antibiotic Raw Powder Lincomycin Hydrochloride Lincomycin HCl CAS 859-18-7
 
 



 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier